Carcinoma de células escamosas em língua pós-transplante de medula óssea por Anemia de Fanconi

Pasquini, Ricardo; Z. Neto, José; Medeiros, Carlos R; Bitencourt, Marco A; Bonfim, Carmem M. S; Moreira, Vaneuza A; Setúbal, Daniela C; Flowers, Mary E. D; Kupka, Elcio; Araújo, Marcos V.
Rev. bras. hematol. hemoter ; 25(4): 239-246, out.-dez. 2003.
Artículo en Portugués | LILACS | ID: lil-359495

Documentos relacionados

  1. Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus.
  2. Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules.
  3. Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis.
  4. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation.
  5. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
  6. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
  7. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
  8. Novel grid and sectoral analyses in monitoring corneal scars.
  9. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
  10. Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective Study.